You have no items in your shopping cart.
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.68 KDa. Observed: 35-50 KDa, reducing conditions
Human
Gly17-Gln208
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 36.58 KDa. Observed: 50 KDa, reducing conditions
Human
Gln32-Leu360
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 34.68 KDa. Observed: 35-42 KDa, reducing conditions
Human
Asn25-His330
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 48.24 KDa. Observed: 65-90 KDa, reducing conditions
Human
Gly24-His458
C-6His
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 53.1 KDa. Observed: 55-65 KDa, reducing conditions
Cynomolgus
Gln22-Glu259
C-Fc
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 63.4 KDa. Observed: 70-110 KDa, reducing conditions
Mouse
Leu22-Lys334
C-Fc
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 73 KDa. Observed: 90-130 KDa, reducing conditions
Cynomolgus
Ser24-Gln430
C-Fc
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 16.7 KDa. Observed: 24- 40 KDa, reducing conditions
Human
Met21-Ala155
C-6His
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 75.7 KDa. Observed: (32-36)&(57 -65) KDa, reducing conditions
Human
Glu16-Asp688
C-6His
50 μg, 500 μg, 1 mg, 10 μgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 36 KDa. Observed: 45-60 KDa, reducing conditions
Human
His22-His340
C-6His
10 μg, 50 μg, 500 μg, 1 mg
